The History of Chromosomal Instability in Genome-Doubled Tumors.

Autor: Baker TM; The Francis Crick Institute, London, United Kingdom.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Medicine, University of California Los Angeles, Los Angeles, California., Lai S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lynch AR; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lesluyes T; The Francis Crick Institute, London, United Kingdom., Yan H; The Francis Crick Institute, London, United Kingdom.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ogilvie HA; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Verfaillie A; The Francis Crick Institute, London, United Kingdom., Dentro S; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany., Bowes AL; The Francis Crick Institute, London, United Kingdom., Pillay N; Research Department of Pathology, Cancer Institute, University College London, London, United Kingdom.; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, United Kingdom., Flanagan AM; Research Department of Pathology, Cancer Institute, University College London, London, United Kingdom.; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, United Kingdom., Swanton C; The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Oncology, University College London Hospitals, London, United Kingdom., Spellman PT; Department of Medicine, University of California Los Angeles, Los Angeles, California., Tarabichi M; The Francis Crick Institute, London, United Kingdom.; Institute for Interdisciplinary Research (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium., Van Loo P; The Francis Crick Institute, London, United Kingdom.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: Cancer discovery [Cancer Discov] 2024 Oct 04; Vol. 14 (10), pp. 1810-1822.

Signatures of copy number alterations in human cancer.

Autor: Steele CD; Research Department of Pathology, Cancer Institute, University College London, London, UK., Abbasi A; Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA, USA.; Department of Bioengineering, UC San Diego, La Jolla, CA, USA.; Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Islam SMA; Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA, USA.; Department of Bioengineering, UC San Diego, La Jolla, CA, USA.; Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Bowes AL; Research Department of Pathology, Cancer Institute, University College London, London, UK.; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Khandekar A; Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA, USA.; Department of Bioengineering, UC San Diego, La Jolla, CA, USA.; Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Haase K; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Hames-Fathi S; Research Department of Pathology, Cancer Institute, University College London, London, UK., Ajayi D; Research Department of Pathology, Cancer Institute, University College London, London, UK., Verfaillie A; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Dhami P; CRUK-UCL Cancer Institute Translational Technology Platform (Genomics), London, UK., McLatchie A; CRUK-UCL Cancer Institute Translational Technology Platform (Genomics), London, UK., Lechner M; Research Department of Oncology, UCL Cancer Institute, London, UK., Light N; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada., Shlien A; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada., Malkin D; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., Feber A; Translational Epigenetics, Division of Molecular Pathology, Institute of Cancer Research, London, UK.; Clinical Genomics, Translational Research Laboratory, Royal Marsden NHS Trust, London, UK., Proszek P; Translational Epigenetics, Division of Molecular Pathology, Institute of Cancer Research, London, UK.; Clinical Genomics, Translational Research Laboratory, Royal Marsden NHS Trust, London, UK., Lesluyes T; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Mertens F; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.; Department of Clinical Genetics and Pathology, Division of Laboratory Medicine, Lund, Sweden., Flanagan AM; Research Department of Pathology, Cancer Institute, University College London, London, UK.; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK., Tarabichi M; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Institute for Interdisciplinary Research, Université Libre de Bruxelles, Brussels, Belgium., Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Alexandrov LB; Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA, USA. L2alexandrov@health.ucsd.edu.; Department of Bioengineering, UC San Diego, La Jolla, CA, USA. L2alexandrov@health.ucsd.edu.; Moores Cancer Center, UC San Diego, La Jolla, CA, USA. L2alexandrov@health.ucsd.edu., Pillay N; Research Department of Pathology, Cancer Institute, University College London, London, UK. N.pillay@ucl.ac.uk.; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK. N.pillay@ucl.ac.uk.

Publikováno v: Nature [Nature] 2022 Jun; Vol. 606 (7916), pp. 984-991. Date of Electronic Publication: 2022 Jun 15.

Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma.

Autor: Chao, Angel^1,2 (AUTHOR), Huang, Chen-Yang^3,4,5 (AUTHOR), Yu, Willie^4,5 (AUTHOR), Lin, Chiao-Yun^1,2 (AUTHOR), Lin, Hao⁶ (AUTHOR), Chao, An-Shine^1,7 (AUTHOR), Lin, Cheng-Tao^1,2 (AUTHOR), Chou, Hung-Hsueh^1,2 (AUTHOR), Huang, Kuang-Gen^1,2 (AUTHOR), Huang, Huei-Jean^1,2 (AUTHOR), Chang, Ting-Chang^1,2 (AUTHOR), Rozen, Steven G.^4,5,8 (AUTHOR), Wu, Ren-Chin^2,9 (AUTHOR) qby@cgmh.org.tw, Lai, Chyong-Huey^1,2 (AUTHOR) laich46@cgmh.org.tw

Publikováno v: BMC Cancer. 11/14/2024, Vol. 24, p1-14. 14p.

Recent Advances in Genomic Approaches for the Detection of Homologous Recombination Deficiency.

Autor: Kim, Yoo-Na^1,2 (AUTHOR), Gulhan, Doga C.^3,4,5 (AUTHOR), Jin, Hu¹ (AUTHOR), Glodzik, Dominik¹ (AUTHOR), Park, Peter J.¹ (AUTHOR) peter_park@hms.harvard.edu

Publikováno v: Cancer Research & Treatment. Oct2024, Vol. 56 Issue 4, p975-990. 16p.

A comprehensive and systematic review of the potential neuroprotective effect of quercetin in rat models of spinal cord injury.

Autor: Zhu, Ke^1,2 (AUTHOR), Zheng, Zhong^1,2 (AUTHOR), Zhang, Ya-yun^1,2 (AUTHOR), Li, Zhuo-yao^1,2 (AUTHOR), Zhou, Ai-fang^1,2 (AUTHOR), Hu, Cai-wei^1,2 (AUTHOR), Shu, Bing^1,2 (AUTHOR), Zhou, Long-yun³ (AUTHOR), Shi, Qi^1,2 (AUTHOR), Wang, Yong-jun^1,2 (AUTHOR), Yao, Min^1,2 (AUTHOR) yaomin19871223@126.com, Cui, Xue-jun^1,2 (AUTHOR) 13917715524@139.com

Publikováno v: Nutritional Neuroscience. Aug2024, Vol. 27 Issue 8, p857-869. 13p.